Login / Signup

Rickettsia conorii O antigen is the target of bactericidal Weil-Felix antibodies.

Hwan Keun KimRanjan PremaratnaDominique M MissiakasOlaf Schneewind
Published in: Proceedings of the National Academy of Sciences of the United States of America (2019)
Rickettsial diseases have long been diagnosed with serum antibodies cross-reactive against Proteus vulgaris (Weil-Felix reaction). Although Weil-Felix antibodies are associated with the development of immunity, their rickettsial target and contribution to disease pathogenesis are not established. Here, we developed a transposon for insertional mutagenesis of Rickettsia conorii, isolating variants defective for replication in cultured cells and in spotted fever pathogenesis. Mutations in the polysaccharide synthesis operon (pso) abolish lipopolysaccharide O-antigen synthesis and Weil-Felix serology and alter outer-membrane protein assembly. Unlike wild-type R. conorii, pso mutants cannot elicit bactericidal antibodies that bind O antigen. The pso operon is conserved among rickettsial pathogens, suggesting that bactericidal antibodies targeting O antigen may generate universal immunity that could be exploited to develop vaccines against rickettsial diseases.
Keyphrases
  • wild type
  • induced apoptosis
  • crispr cas
  • gene expression
  • signaling pathway
  • drug delivery
  • lps induced
  • cancer therapy
  • copy number
  • gram negative